Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 13, 2019 07:58 ET | Source: LexaGene Holdings Inc

LexaGene Provides Corporate Update

BEVERLY, Mass., Nov. 13, 2019 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a biotechnology company that develops genetic analyzers for rapid pathogen...
October 29, 2019 10:48 ET | Source: LexaGene Holdings Inc

LexaGene Announces Closing of CAD$6.64 Million Financing

BEVERLY, Mass., Oct. 29, 2019 (GLOBE NEWSWIRE) -- LexaGene Holdings Inc. (TSX VENTURE: LXG) (OTCQB: LXXGF) ("LexaGene" or the "Company") is pleased to announce that it has closed its previously...
October 02, 2019 07:40 ET | Source: LexaGene Holdings Inc

LexaGene Holdings Announces Pricing of Prospectus Offering

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES BEVERLY, Mass., Oct. 02, 2019 (GLOBE NEWSWIRE) -- LexaGene Holdings Inc. (TSX VENTURE: LXG)...
September 25, 2019 07:58 ET | Source: LexaGene Holdings Inc

LexaGene Holdings Announces Proposed Offering of Units and Filing of Preliminary Prospectus

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES BEVERLY, Mass., Sept. 25, 2019 (GLOBE NEWSWIRE) -- LexaGene Holdings Inc. (TSX VENTURE: LXG)...
September 19, 2019 07:58 ET | Source: LexaGene Holdings Inc

LexaGene Reports on Successful Results from Beta Testing in Human Clinical Diagnostics Laboratory

BEVERLY, Mass., Sept. 19, 2019 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a biotechnology company that develops genetic analyzers for rapid pathogen...
September 17, 2019 07:58 ET | Source: LexaGene Holdings Inc

LexaGene Develops Test for Deadly Mosquito-borne EEE Virus

BEVERLY, Mass., Sept. 17, 2019 (GLOBE NEWSWIRE) -- LexaGene Holdings Inc. (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a biotechnology company that develops genetic analyzers that can rapidly detect...
September 12, 2019 07:58 ET | Source: LexaGene Holdings Inc

LexaGene Announces its Second Hemp-Cannabis Reference Testing Laboratory as a Beta Test Site

BEVERLY, Mass., Sept. 12, 2019 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene”) or the (“Company”), a biotechnology company that develops genetic analyzers for...
September 05, 2019 10:47 ET | Source: LexaGene Holdings Inc

LexaGene Reports on Beta Results from Cannabis-Focused Testing Laboratory

BEVERLY, Mass., Sept. 05, 2019 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a biotechnology company that develops genetic analyzers for rapid pathogen...
August 08, 2019 07:58 ET | Source: LexaGene Holdings Inc

LexaGene to Place Beta Unit in Human Clinical Diagnostics Laboratory

BEVERLY, Mass., Aug. 08, 2019 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a biotechnology company that develops genetic analyzers for rapid pathogen...
July 30, 2019 08:00 ET | Source: LexaGene Holdings Inc

LexaGene Approved by CDC and FDA Antibiotic Resistance Isolate Bank to Receive Samples to Test for Superbugs

BEVERLY, Mass., July 30, 2019 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a biotechnology company that develops genetic analyzers for pathogen detection...